Noninvasive assessment of histological features of nonalcoholic fatty liver disease (NAFLD) has been an intensive research area over the last decade. Herein, we aimed to develop a simple noninvasive score using routine laboratory tests to identify, among individuals at high risk for NAFLD, those with fibrotic nonalcoholic steatohepatitis (NASH) defined as NASH, NAFLD activity score ≥4, and fibrosis stage ≥2.

Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

De Vincentis, Antonio;Carotti, Simone;Perrone, Giuseppe;Tuccinardi, Dario;Manfrini, Silvia;Pozzilli, Paolo;Picardi, Antonio;Caricato, Marco;Vespasiani-Gentilucci, Umberto;
2023-01-01

Abstract

Noninvasive assessment of histological features of nonalcoholic fatty liver disease (NAFLD) has been an intensive research area over the last decade. Herein, we aimed to develop a simple noninvasive score using routine laboratory tests to identify, among individuals at high risk for NAFLD, those with fibrotic nonalcoholic steatohepatitis (NASH) defined as NASH, NAFLD activity score ≥4, and fibrosis stage ≥2.
2023
MAFLD; Metabolic Dysfunction-associated Fatty Liver Disease; Noninvasive tests; Obesity; Type 2 Diabetes
MAFLD; Metabolic Dysfunction-associated Fatty Liver Disease; Noninvasive tests; Obesity; Type 2 Diabetes
File in questo prodotto:
File Dimensione Formato  
20.500.12610-69485.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 637.36 kB
Formato Adobe PDF
637.36 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12610/69485
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 43
social impact